sponsored,DURAVYU,vorolanib,EYP1901

Mashup Score: 6

Addressing the Gaps in Duration of Treatment for Age-Related Macular Degeneration - Retina Today - 15 day(s) ago

Sustained-release tyrosine kinase inhibitors may enable retinal specialists to extend treatment intervals and reduce injection burden while maintaining visual acuity and anatomical control.

Source: retinatoday.com

Categories: General Medicine News, Ophthalmology

Tweet Tweets with this article
- RetinaToday
  
  Learn how sustained delivery of tyrosine kinase inhibitors could be key to addressing an unmet need in nAMD patient care and helping achieve better long-term outcomes. https://t.co/TDDLcsUPFX #sponsored #DURAVYU #vorolanib #EYP1901 https://t.co/THHH7f7iVf